Next, we investigated in other cancer types (apart from breast cancer) whether expression of NSMCE2 and MAL2 is higher in tumor samples when compared to normal tissue and whether high levels of any of these two genes associate with poor survival. This evidence concerns the gene NSMCE2 and breast cancer.